Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial

Support Care Cancer
10 Jan 2022
https://pubmed.ncbi.nlm.nih.gov/35001215/

Naltrexone at low doses (LDN) and its relevance to cancer therapy

Expert Rev Anticancer Ther
02 Feb 2022
https://pubmed.ncbi.nlm.nih.gov/35107043/

 

Burton Berkson, MD, MS, PhD - Cancers and Autoimmune Disease (2013 Conference) (LDN, low dose naltrexone)

 

 

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

 

Dr Akbar Khan - LDN in the treatment of Cancer (2014 Conference) (LDN, low dose naltrexone)

 

Dr Phil Boyle - Low Dose Naltrexone for women's health (2019 Conference) (LDN, low dose naltrexone)

This Presentation was Recorded for The LDN Research Trust 2019 Conference

Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases

Integr Cancer Ther
December 2009
https://pubmed.ncbi.nlm.nih.gov/20042414/